Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Microbiology (Seoul, Korea)|July 4, 2012
Accumulation of lipid production in Chlorella minutissima by triacylglycerol biosynthesis-related genes cloned from Saccharomyces cerevisiae and Yarrowia lipolyticaHsin-Ju Hsieh, Chia-Hung Su, Liang-Jung Chien
Journal of Agricultural and Food Chemistry|August 3, 2006
Production of ascorbyl palmitate by surfactant-coated lipase in organic mediaHsin-Ju Hsieh, Giridhar R Nair, Wen-Teng Wu
Human Heredity|October 27, 2006
Allowing for missing data at highly polymorphic genes when testing for maternal, offspring and maternal-fetal genotype incompatibility effectsHsin-Ju Hsieh, Christina G S Palmer, Janet S Sinsheimer
Statistics in Medicine|October 31, 2002
Assessing chronic disease progression using non-homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in TaiwanHsin-Ju Hsieh, Tony Hsiu-Hsi Chen, Shu-Hui Chang
Preparative Biochemistry & Biotechnology|May 11, 2005
Synthesis of mixed esters of ascorbic acid using methyl esters of palm and soybean oilsHsin-Ju Hsieh, Jech-Wei Chen, R Giridhar, et al.
Applied Microbiology and Biotechnology|September 13, 2007
Production of ascorbic acid glucoside by alginate-entrapped mycelia of Aspergillus nigerHsin-Ju Hsieh, Kai-Yu Tung, Giridhar R Nair, et al.
Pharmaceutical Statistics|April 19, 2026
RABOTS: A Randomized Adaptive Bayesian Optimization Two-Stage Seamless Design for Dose Optimization and Proof-of-Concept EvaluationXiaochen Zhu, Yiwei Li, Jiaju Wu, et al.
Medical Care|September 17, 2005
Differences in cause-specific mortality between Latino and white adultsMitchell D Wong, Tomoko Tagawa, Hsin-Ju Hsieh, et al.
Therapeutic Innovation & Regulatory Science|February 10, 2026
Evaluating Post-Progression Survival in the Context of Progression-Free Survival Benefits: A Revisit of the CodeBreaK200 DesignZhoujingpeng Wei, Yuanyuan Han, Luoying Yang, et al.
The Journal of Allergy and Clinical Immunology|July 19, 2011
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticariaSarbjit Saini, Karin E Rosen, Hsin-Ju Hsieh, et al.
Pageof 3